DaVita Inc. $DVA Shares Purchased by Northern Trust Corp

Key Points

• Northern Trust Corp increased its stake in DaVita Inc. by 20.2% in the first quarter, owning approximately 1.16% of the company, equivalent to $136.24 million.
• DaVita reported $2.95 EPS for the recent quarter, surpassing expectations, with a revenue of $3.38 billion, marking a 6.1% year-over-year increase.
• Wall Street analysts have mixed opinions, with target prices ranging from $148.00 to $169.00 and a consensus rating of "Hold" while DaVita was upgraded to "Buy" by Wall Street Zen.

Northern Trust Corp increased its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 20.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 890,632 shares of the company's stock after purchasing an additional 149,858 shares during the period. Northern Trust Corp owned approximately 1.16% of DaVita worth $136,240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in DVA. Iron Triangle Partners LP purchased a new position in shares of DaVita during the fourth quarter worth $38,946,000. GAMMA Investing LLC raised its holdings in shares of DaVita by 14,695.8% during the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after purchasing an additional 233,222 shares during the last quarter. Nuveen LLC purchased a new position in shares of DaVita during the first quarter worth $20,218,000. Rovin Capital UT ADV purchased a new position in shares of DaVita during the first quarter worth $18,442,000. Finally, Deutsche Bank AG raised its holdings in shares of DaVita by 35.2% during the fourth quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock worth $58,687,000 after purchasing an additional 102,230 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider owned 26,038 shares in the company, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on DVA shares. Barclays reduced their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. Truist Financial set a $148.00 price target on shares of DaVita in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, August 22nd. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, DaVita has an average rating of "Hold" and a consensus price target of $164.00.

DaVita Price Performance

Shares of NYSE DVA traded down $0.87 during trading on Wednesday, hitting $137.81. The company had a trading volume of 270,002 shares, compared to its average volume of 855,904. The stock has a fifty day simple moving average of $139.66 and a two-hundred day simple moving average of $143.41. DaVita Inc. has a fifty-two week low of $126.07 and a fifty-two week high of $179.60. The firm has a market capitalization of $9.85 billion, a price-to-earnings ratio of 13.56, a price-to-earnings-growth ratio of 0.98 and a beta of 1.09. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the business earned $2.00 earnings per share. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.